INTRODUCTION
It is generally considered that Ca21 plays a decisive role in regulating physiologic and biochemical pro-In platelets, calmodulin probably mediates Ca2" control of actin-myosin interaction through the phosphorylation of 20,000-dalton myosin light chain (MLC). ' We have recently suggested (4) that a calmodulin-mediated system, such as Ca2"-dependent MLC phosphorylation plays an important role in the phenomenon of platelet activation, using calmodulin antagonist N-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide (W-7). In the presence of calcium ions, calmodulin antagonists bind to calmodulin and inhibit selectively Ca2+-calmodulin-dependent activation of enzymes (5, 6) .
In the present work, using two series of derivatives of W-7, including a chlorine-deficient analog of W-7 (W-5) and aminoalkyl chain derivatives of W-7 (A-3, A-4, A-5, 1-240, A-6), we attempted to clarify the relationship between their capacity to bind to calmodulin and their potency in inhibiting human platelet aggregation in vitro. We found that the affinity of these naphthalenesulfonamide derivatives for calmodulin was usually in parallel with the extent of inhibition of platelet aggregation.
METHODS
Preparation of calmodulin. Calmodulin from bovine brain was purified to apparent homogeneity, according to the method described previously (7) . The homogeneity was confirmed by sodium dodecyl sulfate (SDS) polyacrylamide gel electrophoresis, according to Weber and Osborn (8) , using 0.1% SDS, 10% polyacrylamide, and 0.1 M sodium phosphate buffer (pH 7.2). Calmodulin levels were assessed ' Abbreviations used in this paper: DTT, dithiothreitol; GFP, gel filtered platelets; I50, concentration of unlabeled compound producing 50% displacement of labeled W-7; IC50, concentration producing 50% inhibition of aggregation; MLC, myosin light chain; PMSF, phenylmethylsulfonyl fluoride; PPP, platelet-poor plasma; PRP, platelet-rich plasma; TNS, 2-p-toluidinylnaphthalene-6-sulfonate; W-7, N-(6-amino-hexyl)-5-chloro-1-naphthalenesulfonamide. according to its ability to increase the activity of calmodulindeficient, Ca2+-dependent cyclic nucleotide phosphodiesterase prepared from bovine brain (7) . 1 U of calmodulin was defined as the amount necessary to produce 50% maximum activation of the calmodulin-deficient phosphodiesterase, under standard conditions, and was equivalent to 10 ng protein.
Binding studies. The binding affinity to calmodulin was determined from the ability of the unlabeled compound to displace radiolabeled W-7 from calmodulin by the equilibrium-binding procedure. The equilibrium-binding procedure on a Sephadex G-50 gel filtration was essentially as described previously (6, 9) . A column (0.9 X 26.5 cm) of Sephadex G-50 
RESULTS
Interaction of naphthalenesulfonamide derivatives with calmodulin. Various naphthalenesulfonamide derivatives were tested for their capacity to bind to calmodulin in the presence of 100 ,M Ca2". We have recently identified the calcium-dependent binding of W-7 to purified calmodulin from bovine brain (6) . (11, 12) , the light chains of myosin have a greater electrophoretic mobility than most other proteins and the phosphorylated 20,000-dalton MLC (position b) of Fig. 1B migrates slightly faster than the unphosphorylated one (from position a of Fig. 1B ). In the presence of 100 MM Ca2+, >90% of 20,000-dalton MLC migrated in the faster position (position b of Fig. 1B) . The quantitative determinations of the amount of 32p incorporated into the 20,000-dalton MLC revealed that 0.80-0.95 mol of 32P/mol of MLC was incorporated in the presence of Ca2 . In the absence of Ca2+ (5 mM EGTA), a small amount of 32p incorporation into 20,000-dalton MLC (Ca2+-independent phosphorylation) was observed ( Fig. 1A and 1B) . This actomyosin fraction contained -50 U of calmodulin/mg protein. This Ca2+-dependent phosphorylation of MLC was not enhanced by addition of exogenous calmodulin from bovine brain to a concentration of 1 AM, suggesting that the amount of calmodulin contained in this fraction is sufficient to produce maximal stimulation of platelet myosin light chain kinase. The treatment of platelet actomyosin with 100 MM W-7 caused a shift of a band to a position of the slower mobility (from position b to a of Fig. 1B) . The shift in the mobility of the band was seen to be accompanied by decreased radioactivity in this region. W-7 produced a dose-dependent inhibition of Ca2+-dependent phosphorylation of 20,000-dalton MLC with an IC50 value of 70 MAM but this compound did not inhibit Ca2+-independent phosphorylation, as shown in Fig. 2 . W-7-induced inhibition of Ca2+-dependent phosphorylation was reduced by addition of calmodulin ( (Fig. 4) . Aggregation response were quantified both as the rate (slope) and maximum extent of aggregation, so that the alternations of the slope were similar to that of the maximum extent of aggregation. Phosphorylation assays were performed as described in Methods. The reaction were performed at 25°C for 10 min. The amount of 32P bound to 20,000-dalton MLC was determined as described under Methods. Each value represents the mean±SEM for four determinations from two separate experiments.
We then compared the IC50 values of naphthalenesulfonamide derivatives on platelet aggregation in order to investigate the relationships between chemical structures and inhibitory action to platelet function.
As shown in Fig. 5 and Table III, Effect of W-7 was examined in human platelet aggregation induced by collagen (2 ug/ml), ADP (5 MM), epinephrine (1 ,ug/ml), sodium arachidonate (0.83 mM), thrombin (0.125 U/ml), and A-23187 (10 WM). The platelets were preincubated without (control) or with W-7 (at final concentrations shown in figure) at 37°C with stirring for 3 min in the aggregometer cuvette before stimulation. gregation among 1-240, W-7, and A-6 were seen though the capacity to compete for the specific bin( of [3H]W-7 to calmodulin increased with the lengt the aminoalkyl chain. W-5 is about four times weE as an inhibitor of platelet aggregation than is W-7. (.uM ) FIGURE 5 Correlation between the affinities of W-7 and its derivatives to calmodulin and their abilities to inhibit platelet aggregation. The data from Tables II and III degree to which these naphthalenesulfonamide derivatives inhibit human platelet aggregation was directly related to their affinity to bind to calmodulin. This is shown graphically in Fig. 5 , which demonstrates a significant positive correlation (r = 0.94). (6, 7, 19) , Ca2"-dependent myosin light chain kinase from chicken gizzard and bovine aorta (6, 20, 21) , and Ca2", Mg2" ATPase of erythrocyte ghost (22) . We have recently demonstrated that W-7 inhibits the Ca2"-activation of phosphodiesterase by direct binding to calmodulin (6) . W-7 not only relaxed vascular strips (15, 19) , but also inhibited platelet aggregation and secretion induced by various aggregating agents. However, the IC50 value of W-7 was indistinguishable for different aggregating agents, therefore this compound probably interacts through a common process in platelet aggregation. It is generally assumed that the biological basis for contractile events in nonmuscle cells such as platelets is similar to the situation in smooth muscle. The regulation of actin-myosin interaction in platelets has been shown to involve phosphorylation-dephosphorylation of the 20,000-dalton MLC (23, 24) . This phosphorylation increases the activity of actin-activated myosin ATPase (25) , and the requirement of phosphorylation for actin-activated ATPase activity of myosin suggests that phosphorylation regulates platelet contractility (26) . Platelet myosin light chain kinase has been identified as a Ca2+-dependent enzyme that requires calmodulin for its activity (10, 27) . Moreover, we have recently suggested that a calmodulinmediated system, such as Ca2+-dependent phosphorylation plays an important role in the phenomenon of platelet secretion (4) . The present studies suggest that the binding affinity of our derivatives for calmodulin and the potency in inhibiting platelet aggregation depend on the chlorination at five position of the naphthalene ring, and also on the length of aminoalkyl chain. As a good correlation between the potency in inhibiting platelet aggregation and affinity to calmodulin was obtained, the inhibitory action of these compounds in platelet aggregation may be due to their effect on Ca2+-calmodulin-dependent processes.
One additional discrepancy found in the platelet aggregation study vis a vis the binding studies is that A-6 and I-240 are equipotent with W-7 in blocking platelet aggregation, although their binding affinity to calmodulin increased steadily with the length of the aminoalkyl chain. One possible explanation would be the difference in penetration of the compound through the platelet membrane, and this aspect is now being investigated. Nonetheless, collectively, our data suggest that the degree to which these naphthalenesulfonamides inhibit the human platelet aggregation in vitro parallels their binding affinity to calmodulin and their potency in inhibition of Ca2"-dependent phosphorylation of 20,000-dalton MLC. Moreover, electron microscopic autoradiography of platelets incubated with radiolabeled W-7 has shown that this agent penetrates platelet membranes and is mainly localized in the platelet hyalomere (unpublished observation). We have recently reported that a hydrophobic probe, 2-p-toluidinylnaphthalene-6-sulfonate (TNS) interacts with calmodulin in the presence of Ca2' and W-7 can suppress the TNS fluorescence (28) . Although the possibility that W-7 binds to other hydrophobic proteins or lipids cannot be excluded, and that synthetic compounds generally have multiple functions, our data are in accord with the hypothesis that the W-7-induced inhibition of platelet aggregation associated with secretion may involve, at least in part, the prevention of calmodulin-mediated processes such as Ca2+-dependent phosphorylation of 20,000-dalton MLC.
